知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

6 records (took 0.014 seconds)

    Composition For Inhibiting Non-Fluorescent Advanced Glycation End Products, And Use Thereof
    1.
    发明申请
    Composition For Inhibiting Non-Fluorescent Advanced Glycation End Products, And Use Thereof 有权

    公开(公告)号：US20220193146A1

    公开(公告)日：2022-06-23

    申请号：US17441827

    申请日：2019-07-17

    Applicant: Korea Food Research Institute

    Inventor： Ho Young Park ,  Yoon Sook Kim ,  Mi Jin Oh ,  Sang Hoon Lee ,  Sang Keun Ha ,  Sang Yoon Choi ,  Yong Kon Park

    IPC: A61K35/74 ,  A23K10/18 ,  A23L33/135 ,  A61P25/00 ,  A61P27/12

    Abstract: The present invention relates to a composition for inhibiting non-fluorescent advanced glycation end products, and a use thereof. More specifically, the present invention relates to: a composition for inhibiting non-fluorescent advanced glycation end products, comprising one or more strains selected from the group consisting of Lactobacillus sp. strains, Lactococcus sp. strains, Enterococcus sp. strains, Bifidobacterium sp. strains, Bacillus sp. strains, Saccharomyces sp. strains, Pediococcus sp. strains, and Leuconostoc sp. strains; and a food composition, a pharmaceutical composition, a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, which have an activity of reducing non-fluorescent advanced glycation end products and comprise the composition. In addition, the present invention relates to a method for producing a non-fluorescent advanced glycation end product inhibitor and a method for inhibiting non-fluorescent advanced glycation end products.

    Novel Strain Having Activity Of Reducing Advanced Glycation End Products And Use Thereof
    2.
    发明申请
    Novel Strain Having Activity Of Reducing Advanced Glycation End Products And Use Thereof 审中-公开

    公开(公告)号：US20200270709A1

    公开(公告)日：2020-08-27

    申请号：US16500913

    申请日：2018-04-06

    Applicant: Korea Food Research Institute

    Inventor： Ho Young Park ,  Yoon Sook Kim ,  Sang Hoon Lee ,  Sang Keun Ha ,  So Young Lee ,  Mi Jin Oh

    IPC: C12R1/225 ,  C12R1/125 ,  C12N1/20 ,  A61K35/747 ,  A61K35/742 ,  A23L33/135 ,  A23K10/18

    Abstract: The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a food composition having the activity of reducing advanced glycation end products and a pharmaceutical composition for preventing or treating a disease caused by advanced glycation end products each of which comprises a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, or a Lactobacillus paracasei KF00816 (accession number KCCM11998P) strain, which are all novel strains; a lysate thereof; or a culture thereof as an active ingredient. In addition, the present invention relates to a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, each of which comprises the novel strain of the present invention, a lysate thereof, or a culture thereof as an active ingredient.

    Strain having activity of reducing advanced glycation end products and use thereof
    3.
    发明授权
    Strain having activity of reducing advanced glycation end products and use thereof 有权

    公开(公告)号：US12156892B2

    公开(公告)日：2024-12-03

    申请号：US16500913

    申请日：2018-04-06

    Applicant: Korea Food Research Institute

    Inventor： Ho Young Park ,  Yoon Sook Kim ,  Sang Hoon Lee ,  Sang Keun Ha ,  So Young Lee ,  Mi Jin Oh

    IPC: A61K35/744 ,  A23K10/18 ,  A23L33/135 ,  A61K35/742 ,  A61K35/747 ,  C12N1/20 ,  C12R1/125 ,  C12R1/225

    Abstract: The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a food composition having the activity of reducing advanced glycation end products and a pharmaceutical composition for preventing or treating a disease caused by advanced glycation end products each of which comprises a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, or a Lactobacillus paracasei KF00816 (accession number KCCM11998P) strain, which are all novel strains; a lysate thereof; or a culture thereof as an active ingredient. In addition, the present invention relates to a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, each of which comprises the novel strain of the present invention, a lysate thereof, or a culture thereof as an active ingredient.

    STRAIN SHOWING LIVER FUNCTION IMPROVING ACTIVITY, AND USE THEREOF
    4.
    发明申请
    STRAIN SHOWING LIVER FUNCTION IMPROVING ACTIVITY, AND USE THEREOF 有权

    公开(公告)号：US20220211781A1

    公开(公告)日：2022-07-07

    申请号：US17611240

    申请日：2020-05-11

    Applicant: Korea Food Research Institute

    Inventor： Ho Young Park ,  Yoon Sook Kim ,  Mi Jin Oh ,  Sang Hoon Lee ,  Hyun Hee Lee ,  Sang Keun Ha ,  Jin Young Hur

    IPC: A61K35/747 ,  A61K35/742 ,  C12N1/20 ,  A61P1/16 ,  A23L33/00 ,  A23L33/135

    Abstract: The present invention relates to a strain having liver function improving activity, and a use thereof. Specifically, the present invention relates to a health food composition for improving liver function and a pharmaceutical composition for improving liver function, which contain, as an active ingredient, one or more strains selected from the group consisting of a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, and a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a lysate thereof or a culture product thereof. The strain of the present invention shows excellent activity in inhibiting the activity of alanine aminotransferase (ALT) or aspartate aminotransferase (AST), inhibiting an increase in the concentration of total cholesterol or triglycerides in the liver, and inhibiting fat accumulation in the liver, thereby being effectively usable in the preparation of a food composition and a pharmaceutical composition for improving liver function.

Patent Agency Ranking